Clinical Trial Update: Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial. [Phase 4]

View source ↗

Summary

A phase 4 randomized, single-blinded trial assessing the hemodynamic profile of terlipressin and octreotide in patients with liver cirrhosis and portal hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)
• Terlipressin (terlipressin)

Snippet

Sponsor: Juan A. Arnaiz | Conditions: Liver Cirrhosis Portal | Phase 4 | Status: UNKNOWN